The U.S. is preparing to embark on an ambitious and controversial program — offering a third dose of the Pfizer or Moderna vaccine starting Sept. 20 in a bid to further fight COVID-19 infections, despite international criticism highlighting that many countries are still fighting to acquire first doses.
0 Comments